Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | APP | P05067 | 1/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.53 |
| ▸ | PAM | P19021 | 2/20 | 0.51 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | CTSK | P43235 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4353439 | 1.00 | DGKA (0.66) | DGKATDP1APPALOX5PAM | |
| SCHEMBL10766992 | 1.00 | DGKA (0.66) | DGKATDP1APPALOX5PAM | |
| SCHEMBL28381584 | 1.00 | DGKA (0.66) | DGKATDP1APPALOX5PAM | |
| SCHEMBL873938 | 1.00 | DGKA (0.66) | DGKATDP1APPALOX5PAM | |
| SCHEMBL8663024 | 1.00 | DGKA (0.66) | DGKATDP1APPALOX5PAM | |
| SCHEMBL3506704 | 1.00 | DGKA (0.66) | DGKATDP1APPALOX5PAM | |
| SCHEMBL873318 | 1.00 | DGKA (0.66) | DGKATDP1APPALOX5PAM | |
| SCHEMBL473563 | 0.98 | TDP1 (0.64) | DGKATDP1APPALOX5PAM | |
| SCHEMBL27614560 | 0.97 | DGKA (0.62) | DGKATDP1APPALOX5DNM1 | |
| Formic Acid SCHEMBL28726221 | 0.94 | DGKA (0.58) | DGKATDP1APPALOX5PAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115363188-A | Blueberry-flavored composition and preparation method thereof | 广州和泉食品有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-114317114-A | Momordica grosvenori solid spice and preparation method and application thereof | 河南中烟工业有限责任公司 | 2022-04-12 | — | — | CN | claimed |
| CN-109674667-B | Shampoo essence with lasting fragrance retention | 毓美生物科技(广州)有限公司 | 2022-01-21 | — | — | CN | claimed |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| CN-116327612-A | Washing and bathing product with microcapsules gradually releasing fragrance for 72 hours and preparation method thereof | 广州美思生物技术有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-115363188-A | Blueberry-flavored composition and preparation method thereof | 广州和泉食品有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-114317114-A | Momordica grosvenori solid spice and preparation method and application thereof | 河南中烟工业有限责任公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-114097773-A | Suspending agent capable of preventing and controlling pine wood nematode disease | 福建农林大学 | 2022-03-01 | — | — | CN | disclosed |
| CN-109674667-B | Shampoo essence with lasting fragrance retention | 毓美生物科技(广州)有限公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-102866605-B | The toner that can decolour and manufacture method thereof | Toshiba-tec K. K. (JP) | 2015-11-18 | — | — | CN | disclosed |
| CN-102866605-A | Decolorable toner and process for production thereof | TOSHIBA TEC KK | 2013-01-09 | — | — | CN | disclosed |
| EP-1335700-A1 | COSMETIC AND PHARMACEUTICAL COMPOSITION COMPRISING CHELATING/SEQUESTERING AGENTS AND THEIR COSMETIC OR DERMATOLOGICAL USE | JOHNSON & JOHNSON GmbH (DE) | 2003-08-20 | — | — | EP | disclosed |
| WO-2002019981-A2 | COSMETIC AND PHARMACEUTICAL COMPOSITION COMPRISING CHELATING/SEQUESTERING AGENTS AND THEIR COSMETIC AND DERMATOLOGICAL USE | JOHNSON & JOHNSON GMBH (DE) | 2002-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | DGKA 1309/4885TDP1 4632/4885APP 3265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.